February 1, 2024 · Form 4 insider transaction
Delaet Ingrid sold 623 shares of Neurocrine Biosciences, Inc. at $139.77 per share, a transaction worth $87.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Sale of 623 shares of common stock issued upon vesting of 1,179 restricted stock units on February 1, 2024 to cover payroll and withholding taxes, with the balance of the shares (556) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.